Reviva Historical Financial Ratios

RVPH Stock  USD 2.61  0.16  5.78%   
Reviva Pharmaceuticals is promptly reporting on over 78 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 0.45, Invested Capital of 0.0, Average Payables of 3.5 M or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Reviva Pharmaceuticals financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

About Reviva Financial Ratios Analysis

Reviva PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Reviva Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Reviva financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Reviva Pharmaceuticals history.

Reviva Pharmaceuticals Financial Ratios Chart

As of now, Reviva Pharmaceuticals' PB Ratio is increasing as compared to previous years. The Reviva Pharmaceuticals' current ROIC is estimated to increase to about 3.1 B, while Free Cash Flow Yield is projected to decrease to (0.24).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Reviva Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Reviva Pharmaceuticals sales, a figure that is much harder to manipulate than other Reviva Pharmaceuticals Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Reviva Pharmaceuticals Holdings dividend as a percentage of Reviva Pharmaceuticals stock price. Reviva Pharmaceuticals dividend yield is a measure of Reviva Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Reviva Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.
Most ratios from Reviva Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
As of now, Reviva Pharmaceuticals' PB Ratio is increasing as compared to previous years. The Reviva Pharmaceuticals' current ROIC is estimated to increase to about 3.1 B, while Free Cash Flow Yield is projected to decrease to (0.24).

Reviva Pharmaceuticals fundamentals Correlations

0.64-0.84-0.880.911.0-0.880.93-0.93-0.88-0.830.82-0.070.82-0.880.2-0.930.810.87-0.920.81-0.930.720.210.640.93
0.64-0.89-0.910.60.64-0.910.36-0.36-0.34-0.950.96-0.510.96-0.340.75-0.360.960.92-0.360.96-0.360.990.821.00.36
-0.84-0.890.92-0.85-0.840.92-0.610.610.580.98-0.980.5-0.980.58-0.590.61-0.98-0.980.61-0.980.61-0.94-0.66-0.89-0.61
-0.88-0.910.92-0.83-0.881.0-0.660.660.630.97-0.970.22-0.970.63-0.490.66-0.97-0.970.66-0.970.66-0.94-0.52-0.91-0.66
0.910.6-0.85-0.830.91-0.830.75-0.75-0.71-0.820.8-0.030.8-0.710.17-0.750.80.85-0.750.8-0.750.70.180.60.75
1.00.64-0.84-0.880.91-0.880.93-0.93-0.88-0.830.82-0.070.82-0.880.2-0.930.810.87-0.920.81-0.930.720.210.640.93
-0.88-0.910.921.0-0.83-0.88-0.660.660.630.97-0.970.22-0.970.63-0.490.66-0.97-0.970.66-0.970.66-0.94-0.52-0.91-0.66
0.930.36-0.61-0.660.750.93-0.66-1.0-0.95-0.580.560.060.56-0.95-0.04-1.00.550.63-1.00.55-1.00.44-0.040.361.0
-0.93-0.360.610.66-0.75-0.930.66-1.00.930.58-0.56-0.06-0.560.930.031.0-0.55-0.631.0-0.551.0-0.440.04-0.36-1.0
-0.88-0.340.580.63-0.71-0.880.63-0.950.930.54-0.52-0.05-0.521.00.070.93-0.52-0.60.93-0.520.93-0.410.04-0.34-0.95
-0.83-0.950.980.97-0.82-0.830.97-0.580.580.54-1.00.41-1.00.54-0.610.58-1.0-1.00.58-1.00.58-0.98-0.66-0.95-0.58
0.820.96-0.98-0.970.80.82-0.970.56-0.56-0.52-1.0-0.421.0-0.520.63-0.561.00.99-0.561.0-0.560.990.680.960.56
-0.07-0.510.50.22-0.03-0.070.220.06-0.06-0.050.41-0.42-0.42-0.05-0.74-0.06-0.43-0.39-0.06-0.43-0.06-0.48-0.88-0.510.06
0.820.96-0.98-0.970.80.82-0.970.56-0.56-0.52-1.01.0-0.42-0.520.63-0.561.00.99-0.561.0-0.560.990.680.960.56
-0.88-0.340.580.63-0.71-0.880.63-0.950.931.00.54-0.52-0.05-0.520.070.93-0.52-0.60.93-0.520.93-0.410.04-0.34-0.95
0.20.75-0.59-0.490.170.2-0.49-0.040.030.07-0.610.63-0.740.630.070.030.630.570.030.630.030.710.880.75-0.04
-0.93-0.360.610.66-0.75-0.930.66-1.01.00.930.58-0.56-0.06-0.560.930.03-0.55-0.631.0-0.551.0-0.440.04-0.36-1.0
0.810.96-0.98-0.970.80.81-0.970.55-0.55-0.52-1.01.0-0.431.0-0.520.63-0.550.99-0.551.0-0.550.990.680.960.55
0.870.92-0.98-0.970.850.87-0.970.63-0.63-0.6-1.00.99-0.390.99-0.60.57-0.630.99-0.630.99-0.630.960.620.920.63
-0.92-0.360.610.66-0.75-0.920.66-1.01.00.930.58-0.56-0.06-0.560.930.031.0-0.55-0.63-0.551.0-0.440.04-0.36-1.0
0.810.96-0.98-0.970.80.81-0.970.55-0.55-0.52-1.01.0-0.431.0-0.520.63-0.551.00.99-0.55-0.550.990.680.960.55
-0.93-0.360.610.66-0.75-0.930.66-1.01.00.930.58-0.56-0.06-0.560.930.031.0-0.55-0.631.0-0.55-0.440.04-0.36-1.0
0.720.99-0.94-0.940.70.72-0.940.44-0.44-0.41-0.980.99-0.480.99-0.410.71-0.440.990.96-0.440.99-0.440.770.990.44
0.210.82-0.66-0.520.180.21-0.52-0.040.040.04-0.660.68-0.880.680.040.880.040.680.620.040.680.040.770.82-0.04
0.641.0-0.89-0.910.60.64-0.910.36-0.36-0.34-0.950.96-0.510.96-0.340.75-0.360.960.92-0.360.96-0.360.990.820.36
0.930.36-0.61-0.660.750.93-0.661.0-1.0-0.95-0.580.560.060.56-0.95-0.04-1.00.550.63-1.00.55-1.00.44-0.040.36
Click cells to compare fundamentals

Reviva Pharmaceuticals Account Relationship Matchups

Reviva Pharmaceuticals fundamentals Accounts

201920202021202220232024 (projected)
Income Quality0.260.981.250.780.720.62
Return On Tangible Assets(325.7)(0.43)(0.27)(1.29)(1.7M)(1.6M)
Effective Tax Rate(9.46E-4)(2.11E-4)(7.05E-4)(8.54E-4)431.89453.48
Return On Capital Employed0.0553(0.33)(0.35)(1.89)(6.1M)(5.8M)

Currently Active Assets on Macroaxis

When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.08)
Return On Assets
(2.34)
Return On Equity
(17.95)
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.